Arcus Biosciences RCUS CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Arcus Biosciences's capex?
- Arcus Biosciences (RCUS) reported capex of $0 in Q1 2026.
- How has Arcus Biosciences's capex changed year-over-year?
- Arcus Biosciences's capex decreased by 100.0% year-over-year, from $1M to $0.
- What is the long-term trend for Arcus Biosciences's capex?
- Over 3 years (2021 to 2024), Arcus Biosciences's capex has grown at a -38.7% compound annual growth rate (CAGR), from $26M to $6M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.